Patient receiving a vaccine

The AMA recognizes the critical importance of scientific integrity, transparency, and public trust  as we fight to contain the global spread of COVID-19 and plan for the authorization, distribution and administration of COVID-19 vaccines.

Find COVID-19 vaccine CPT® codes

Use this AMA tool to determine the appropriate CPT code combination for the type and dose of vaccine being used.


COVID-19 webinar: Vaccine safety and delivery

Friday, Jan. 29, 2021, 3 p.m. Central | 4 p.m. Eastern

The AMA welcomes back Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), to discuss the road ahead now that vaccines are available. Learn more and register.

The AMA recently published two new resources for on what patients need to know regarding COVID-19 transmission and wearing face masks: 

The Ad Council and the COVID Collaborative, a coalition of the nation’s experts in health, education and the economy, have created a new resource designed to address health professional’s questions about COVID-19 vaccination. The video series was developed in collaboration with the AMA, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases and other top health and medical institutions.

Topics addressed include safety, availability, cost, side effects, vaccine administration, answering patients’ questions and more. Learn more about this joint effort and watch the series now.

Hosted by AMA physician leaders, each installment of this webinar series aims to gain fact-based insights from the nation’s highest-ranking subject matter experts working to protect the health of the public, particularly during the COVID-19 pandemic.

FDA review process for COVID-19 vaccine candidates webinar

In this webinar, AMA leaders and experts from the FDA provide a comprehensive overview of the COVID-19 vaccine and an inside look at the FDA development and approval process of a vaccine. Speakers also discuss the differences between the Emergency Use Authorization (EUA) and Biologic License Application (BLA) pathways.

Watch now or read the transcript on FDA review process for COVID-19 vaccine candidates.


CDC Update on COVID-19 vaccine development webinar

The purpose of this webinar discussion focuses on ways to help physicians and the public have a better understanding of the vaccine development process, as well as allocation and distribution of a vaccine, or vaccines, when they become available. 

Watch now or read the transcript on CDC Update on COVID-19 vaccine development.


What physicians need to know about vaccine development webinar

Peter Marks, MD, PhD, the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration, discusses the latest developments on the road to effective COVID-19 vaccines, including a deep dive into the Emergency Use Authorization (EUA) process, specifically how the timeline has been shortened from a matter of years to a matter of months.

Watch now or read the transcript on What Physicians Need to Know About Vaccine Development.

Additional resources

Static Up
97
Featured Stories